Alliancebernstein L.P. Bridge Bio Pharma, Inc. Transaction History

Alliancebernstein L.P.

$300 Billion
Q3 2025

A detailed history of Alliancebernstein L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 2,328,715 shares of BBIO stock, worth $155 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,328,715

Previous 2,470,558 5.74%

Holding current value

$155 Million

Previous $107 Million 13.38%

% of portfolio

0.04%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$42.78 - $54.29 $6.07 Million - $7.7 Million	-141,843 Reduced 5.74%	2,328,715 $121 Million
Q2 2025 Aug 14, 2025	SELL	$30.14 - $45.12 $6.44 Million - $9.64 Million	-213,588 Reduced 7.96%	2,470,558 $107 Million
Q1 2025 May 15, 2025	SELL	$28.12 - $37.59 $3.1 Million - $4.14 Million	-110,146 Reduced 3.94%	2,684,146 $92.8 Million
Q4 2024 Feb 12, 2025	SELL	$22.35 - $29.5 $745,908 - $984,533	-33,374 Reduced 1.18%	2,794,292 $76.7 Million
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $8.97 Million - $11.7 Million	375,262 Added 15.3%	2,827,666 $72 Million

Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $9.01 Million - $12.2 Million	-391,895 Reduced 13.78%	2,452,404 $62.1 Million
Q1 2024 May 14, 2024	BUY	$27.35 - $40.45 $7.85 Million - $11.6 Million	286,883 Added 11.22%	2,844,299 $87.9 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $3.81 Million - $6.97 Million	-158,724 Reduced 5.84%	2,557,416 $103 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $43.2 Million - $89.6 Million	2,560,549 Added 1645.69%	2,716,140 $71.6 Million
Q2 2023 Aug 15, 2023	BUY	$13.29 - $18.01 $303,450 - $411,222	22,833 Added 17.2%	155,591 $2.68 Million
Q1 2023 May 15, 2023	SELL	$7.17 - $18.55 $1,434 - $3,710	-200 Reduced 0.15%	132,758 $2.2 Million
Q3 2022 Nov 15, 2022	SELL	$7.94 - $12.36 $1.47 Million - $2.29 Million	-185,258 Reduced 58.22%	132,958 $1.32 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $200,668 - $467,584	-38,516 Reduced 10.8%	318,216 $2.89 Million
Q1 2022 May 13, 2022	SELL	$7.34 - $17.16 $441,853 - $1.03 Million	-60,198 Reduced 14.44%	356,732 $3.62 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $3.18 Million - $14.9 Million	279,232 Added 202.79%	416,930 $6.95 Million
Q3 2021 Nov 10, 2021	BUY	$46.87 - $64.24 $82,022 - $112,419	1,750 Added 1.29%	137,698 $6.45 Million
Q2 2021 Jul 30, 2021	SELL	$46.47 - $63.93 $111,992 - $154,071	-2,410 Reduced 1.74%	135,948 $8.29 Million
Q1 2021 May 06, 2021	BUY	$55.47 - $72.35 $1.91 Million - $2.49 Million	34,374 Added 33.06%	138,358 $8.52 Million
Q3 2020 Nov 12, 2020	SELL	$27.2 - $42.19 $66,177 - $102,648	-2,433 Reduced 2.29%	103,984 $3.9 Million
Q2 2020 Aug 13, 2020	BUY	$22.22 - $35.69 $151,096 - $242,691	6,800 Added 6.83%	106,417 $3.47 Million
Q1 2020 May 14, 2020	BUY	$16.11 - $36.23 $1.16 Million - $2.61 Million	72,164 Added 262.86%	99,617 $2.89 Million
Q4 2019 Feb 18, 2020	BUY	$17.96 - $46.63 $493,055 - $1.28 Million	27,453 New	27,453 $962,000

Others Institutions Holding BBIO

# of Institutions

446

Shares Held

184M

Call Options Held

11.3M

Put Options Held

1.84M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $9.84B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Bridge Bio Pharma, Inc. Transaction History